Codexis Names Pharmaceutical Industry Veteran Bernard J.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Codexis Names Pharmaceutical Industry Veteran Bernard J. Kelley Chairman of the Board

REDWOOD CITY, Calif., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a leading protein engineering company, announces that Bernard J. Kelley has been named Chairman of the Board, effective November 29, 2016. Mr. Kelley has served as a Director of Codexis since April 2004.  He has succeeded former Board Chairman Thomas Baruch, who will continue as a Director and has been named Codexis Chairman Emeritus, an honorary title to recognize his contributions to the company.

“Bernie’s service on our Board of Directors, as well as his impressive background in pharmaceutical manufacturing along with senior management and financial operations acumen have been instrumental in establishing Codexis as a leader in enzyme development,” said Mr. Baruch. “We are delighted that as Chairman of the Board he will continue to build and guide our strategic vision to grow our current lines of business and to expand into adjacent markets.”

“Tom Baruch has been instrumental in leading the Board since Codexis was formed over fourteen years ago, and most recently oversaw the company’s transformational growth back into the pharmaceutical sector,” said John Nicols, Codexis President and CEO. “On behalf of our entire organization, I want to recognize and thank Tom for his legacy of leadership at Codexis.”

Prior to joining the Codexis Board, Mr. Kelley was President of the Merck Manufacturing Division where he was responsible for chemical, pharmaceutical and biological manufacturing and directed the activities of corporate engineering and global procurement.  He also served as a member of the Merck Management Committee through his retirement in 2003.  Mr. Kelley previously served as a Director of MAP Pharmaceuticals, Inc., a biotechnology company focused on developing inhalation-based therapies, as well as a Director of Aegis Analytical Corporation, an enterprise software company.  He holds a B.S. in engineering from the U.S. Naval Academy.

About CodeEvolver ® Protein Engineering Platform Technology

Codexis’ proprietary CodeEvolver ® protein engineering platform enables the rapid development of custom-designed enzymes that are highly optimized for a specific function. The CodeEvolver ® platform is comprised of proprietary methods for the optimization of proteins through the design and generation of diverse genetic libraries, automated screening techniques, algorithms for the interpretation of screening data and predictive modelling.  The Codexis CodeEvolver ® platform technology is covered by more than 225 issued patents and pending patent applications worldwide.

About Codexis, Inc.

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com .

Forward-Looking Statements

This press release contains forward-looking statements relating to the election of Bernard J. Kelley as Chairman of the Board of Directors and the expectation of Codexis to grow its current lines of business and to expand into adjacent markets. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis’ control and that could materially affect actual results. Factors that could materially affect actual results include Codexis’ dependence on its licensees and collaborators; Codexis’ dependence on a limited number of products and customers in its pharmaceutical business; potential adverse effects to Codexis’ business if its customers’ pharmaceutical products are not received well in the markets; Codexis’ ability to deploy its technology platform in new market spaces; Codexis’ dependence on key personnel; Codexis’ ability to compete may decline if it loses some of its intellectual property rights; third party claims that Codexis infringes third party intellectual property rights; and Codexis could face increased competition if third parties misappropriate Codexis biocatalysts. Additional factors that could materially affect actual results can be found in Codexis’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 8, 2016 and in Codexis’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2016, including, in each case, under the caption “Risk Factors.” Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

Codexis Contacts:

Investors LHA Jody Cain, 310-691-7100 jcain@lhai.com

Media That’s Nice LLC Guy Tiene, 212-366-4455 Guy@thatsnice.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 258

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 459

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 157

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 121

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 332

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 509

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 250

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Atlanticus Holdings Celebrates Substantial Year-End Growth

Updated Category News Views 176

Impressive Financial Results for Atlanticus Holdings Atlanticus Holdings Corporation (NASDAQ: ATLC), known for empowering financial inclusivity through innovative technology, has reported remarkable achievements in its financial results for the fourth quarter and the full year ended December 31, 2024. The company served an impressive total of 3.7 million accounts,...

Continue Reading
Jonas Warrer Expands Stake in Gentoo Media: Key Insights

Updated Category News Views 262

Jonas Warrer's Strategic Move in Gentoo Media Holdings Recent transactions in the stock market have captivated the attention of many investors, particularly when they involve significant figures in the industry. One such notable event occurred when Jonas Warrer, CEO and primary insider of Gentoo Media, made headlines by acquiring a substantial number of shares in his own...

Continue Reading
Venture Global Inc. Faces Class Action Over Investor Losses

Updated Category News Views 233

Venture Global Inc. Investors Advised on Class Action For investors in Venture Global Inc. seeking justice, significant legal developments have unfolded. The company, known for its ambitious initiatives in the liquefied natural gas sector, is currently facing serious allegations in a class action lawsuit. For those who lost money in their investments, it's crucial to...

Continue Reading
Global Roaming Tariff Market Expected to Hit USD 140.3 Billion

Updated Category News Views 329

Overview of the Roaming Tariff Market Growth The Roaming Tariff Market has entered an exciting phase, anticipated to soar to USD 140.3 billion by 2032, after reaching USD 77.5 billion in 2023. Such growth, at a compound annual growth rate (CAGR) of 6.83% from 2024 to 2032, is invigorated by the widespread expansion of 5G technology and increasing global travel demand. Key...

Continue Reading
Investing Insights: Analyzing Charles Schwab's Market Position

Updated Category News Views 263

Understanding the Recent Shift in Charles Schwab's Market Position Charles Schwab's short percent of float has recently experienced a significant increase, rising by 67.5% as indicated by the latest reports. Currently, there are 22.74 million shares sold short, which accounts for 1.34% of the total regular shares available for trading. With this short interest, traders...

Continue Reading